Dexcom (DXCM) FY2022 results: revenue $2.9 billion, up 18.8% on the year
Dexcom Inc. (DXCM) reported revenue of $2.9 billion for fiscal 2022, the year ended 31 December 2022, up 18.8% on the year before. Net income was $341 million, up 57.3%, and diluted earnings per share $0.82. The figures are the company's own, from the 10-K it filed with the SEC on 9 February 2023.
Revenue
$2.9 billion
+18.8% on the year
FY2015FY2022
Operating margin
13.4%
10.9% a year earlier
FY2015FY2022
Net income
$341 million
+57.3% on the year
FY2015FY2022
Diluted EPS
$0.82
+54.7% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
670
442
476
+51.3%
Capital expenditure
365
389
199
-6.3%
Free cash flow
305
53.3
277
+471.7%
Free cash flow margin
10.5%
2.2%
14.4%
Cash from investing
-522
-216
-1,018
Cash from financing
-552
10.4
912
Depreciation and amortisation
156
102
67.1
+52.8%
Share-based compensation
126
113
119
+11.6%
Buybacks
558
0.0
0.0
Diluted shares, weighted
428m
429m
420m
-0.3%
Shares outstanding at period end
386m
97m
96m
+298.2%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
2,132
2,042
1,552
+4.4%
Non-controlling interest
n/a
n/a
275
Debt
1,970
1,982
1,667
-0.6%
Operating lease liabilities
94.6
98.6
102
-4.1%
Finance lease liabilities
59.6
57.0
54.0
+4.6%
Other liabilities
1,135
754
641
+50.6%
Total liabilities and equity
5,392
4,933
4,290
+9.3%
Fixed assets
1,056
802
515
+31.7%
Goodwill
25.7
26.5
19.3
-3.0%
Intangible assets
173
31.5
n/a
+450.2%
Investments
1,829
1,681
n/a
+8.8%
Securities held for sale or to maturity
n/a
n/a
1,890
Cash and equivalents
642
1,053
818
-39.0%
Receivables
713
514
428
+38.7%
Inventory
307
357
235
-14.2%
Other assets
646
469
385
+37.8%
Total assets
5,392
4,933
4,290
+9.3%
10-K for the year ended 31 December 2022, filed 9 February 2023: the filing.